• SENSEX 73,709.69
    -143.21 (--0.19%)
  • BANKNIFTY 54,976.90
    -511.20 (--0.92%)
  • Max Healthcare
    811.50 811.50(%)
  • L&T Technology
    4,140.50 4,746.95(%)
  • Bajaj Finance
    919.00 788.40(%)
  • NSE
    1,705.00 1,705.00(%)
  • Reliance Industries
    1,234.60 1,611.20(%)
  • TCS
    2,533.10 3,336.70(%)
  • PC Jeweller
    19.14 19.14(%)
  • Cupid
    343.65 369.70(%)
  • HD Fire Protect
    338.00 338.00(%)
  • Infosys
    1,171.00 1,727.85(%)
  • ZF Commercial
    2,073.00 2,053.38(%)
  • Aditya Infotech
    3,879.70 1,301.10(%)
  • HDFC Bank
    698.35 682.00(%)
  • Fractal Analyt.
    828.00 1,119.60(%)
  • SS Retail
    724.90 888.00(%)
  • ICICI Bank
    1,409.50 1,479.90(%)
  • APL Apollo Tubes
    2,052.10 1,691.05(%)
  • Sun Pharma.Inds.
    1,721.70 1,583.60(%)
  • Netweb Technol.
    4,575.95 2,942.45(%)
  • CreditAcc. Gram.
    1,129.35 1,112.90(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zenith Health Care Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5117.0
  • ISIN : INE812B01026
3.02 0 (-0.98%)
  • As on 21 Oct 2026 (EOD)

  • Today’s Low

    2.99

  • Today’s High

    3.07

  • Open

    3.02

  • Perv Close

    3.05

  • 52W Low

    2.23

  • 52W High

    4.17

Key Indicators

  • P/E(TTM)

    100.67

  • Mar.Cap (₹Cr.)

    16.23

  • Div & Yield %

    0.00

  • Book Value(₹)

    1.38

  • Debt-Equity Ratio

    -0.98

  • AGM Date

    21-Oct-2026

  • EPS

    0.03

  • P/E Ratio

    100.67

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    16.23

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.37

  • BV (₹)

    1.40

  • Sales( ₹ in Cr.)

    10.52

  • NP (in Cr.)

    0.01

  • NP Var(%)

    112.0

  • Div%

    0.0

  • CPS (₹)

    0.00

  • EPS (₹)

    0.00

  • Traded Value (₹ in Lakhs)

    16.23

  • 52 Week High

    4.17

  • 52 Week Low

    2.23

  • Price BSE

    3.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    16.23

  • P/C Ratio

    61.20

  • P/E Ratio

    3,161.10

  • Price Vs.BV

    0.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 10.52 11.33 14.47 13.13 22.36 13.74
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 10.52 11.33 14.47 13.13 22.36 13.74
Other Income 0.41 0.43 0.26 0.38 0.52 0.46
Stock Adjustments 0.13 0.35 -0.84 -0.41 0.23 1.14
Total Income 11.06 12.11 13.89 13.10 23.11 15.34
EXPENDITURE :            
Raw Materials 4.97 5.77 7.50 7.66 12.84 9.34
Power and Fuel Cost 0.20 0.19 0.20 0.06 0.06 0.07
Employee Cost 1.41 1.35 1.18 1.28 1.37 1.05
Other Manufacturing Expenses 0.75 0.72 0.61 0.27 0.27 0.23
Selling and Administration Expenses 3.07 3.25 3.33 3.02 7.57 3.82
Miscellaneous Expenses 0.38 0.31 0.58 0.39 0.03 0.00
Employee Benefit Expenses 1.41 1.35 1.18 1.28 1.37 1.05
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 10.78 11.59 13.40 12.69 22.14 14.52
Operating Profit 0.28 0.52 0.50 0.41 0.97 0.82
Interest 0.01 0.01 0.01 0.01 0.01 0.01
Gross Profit 0.27 0.51 0.49 0.40 0.96 0.81
Depreciation 0.26 0.23 0.21 0.28 0.36 0.25
Profit Before Tax 0.01 0.28 0.28 0.12 0.60 0.56
Current Tax 0.04 0.08 0.07 0.03 0.18 0.13
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.02 0.14 0.00 0.01 0.11 -0.02
Reported Net Profit 0.01 0.07 0.20 0.08 0.31 0.44
Extraordinary Items 0.00 0.11 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.01 -0.04 0.20 0.08 0.31 0.44
Adjustment below Net Profit 0.01 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 2.02 1.95 1.74 1.76 1.45 1.01
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 2.03 2.02 1.95 1.84 1.76 1.45
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.00 0.01 0.04 0.01 0.06 0.08
Earnings Per Share(Adj)-Unit Curr 0.00 0.01 0.04 0.01 0.06 0.08
Book Value 1.38 1.38 1.37 1.35 1.33 1.27
Book Value(Adj)-Unit Curr 1.38 1.38 1.37 1.35 1.33 1.27

Shareholding Pattern

  • Promoter Group

    28.74%

  • Public Share Holding

    71.26%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,252,550 4.19 2,252,550 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 13,191,029 24.55 13,001,529 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,443,579 28.74 15,254,079 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 211,000 0.39 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 211,000 0.39 0 1
2] Non Institution
Bodies Corporate 2,544,100 4.73 1,922,600 28
Clearing Members 46,996 0.09 46,996 7
Directors of their Relatives 0 0.00 0 0
Employees 13,500 0.03 0 15
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 746,276 1.39 571,276 136
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 409,120 0.76 409,120 112
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,028,692 5.64 394,192 6
Individuals holding nominal share capital up to Rs. 1 lakh 31,292,637 58.23 23,262,137 38,029
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 38,084,421 70.87 26,609,421 38,334
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 53,739,000 100.00 41,863,500 38,345

Company Background

Zenith Health Care LtdPharmaceuticals - Indian - Formulations

  • Zenith Health Care Ltd
  • BSE Code : 5117.0
  • ISIN : INE812B01026

  • Incorporation Year

    1994

  • Registered Office

    504 Iscon Elegance S G Road
    Nr Ananddham Jain Derasar, Ahmedabad,
    Gujarat-380051

  • Telephone

    91-79-66168889/66168890

  • FAX

    91-79-66168891

  • Chairman

    Mahendra C Raycha

  • Managing Director

    Mahendra C Raycha

  • Company Secretary

    Mihir Satishkumar Shah

  • Auditor

    Doshi Doshi & Co

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    Big Share Services Pvt Ltd
    E-2/3 Saki Vihar Rd ,
    Ansa Indl Estate ,Saki Naka Andheri-E
    Mumbai - Mumbai - 400 072

Zenith Health Care Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zenith Health 3.02 10.94 10.52 100.67 0.40
Abbott India 25,744.40 7,217.19 6,929.05 33.88 43.78
Astrazeneca Phar 6,076.90 2,304.07 2,275.58 89.56 27.86
Glaxosmi. Pharma 2,463.75 3,932.76 3,790.20 39.36 58.17
Novartis India 1,768.90 393.10 354.33 44.67 15.94
Cipla 1,313.80 20,102.60 18,979.95 34.53 13.88
Bliss GVS Pharma 609.80 773.53 729.81 56.67 12.51
Amrutanjan Healt 495.10 520.13 502.55 26.52 24.16
Fermenta Biotec. 465.60 474.15 450.25 21.74 18.77
Guj. Themis Bio. 351.30 168.25 165.82 93.93 18.05
Ambalal Sarabhai 36.94 19.52 3.94 68.41 6.77